Provided by Tiger Fintech (Singapore) Pte. Ltd.

Castle Biosciences, Inc.

18.54
-0.7300-3.79%
Post-market: 18.540.00000.00%16:04 EDT
Volume:581.56K
Turnover:10.76M
Market Cap:535.29M
PE:-100.50
High:19.36
Open:19.12
Low:18.08
Close:19.27
Loading ...
May 23, 2025

Major Issues Report

Form 8-K - Current report
May 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2025

Major Issues Report

Form 8-K - Current report
Apr 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Feb 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 04, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2024

Major Issues Report

Form 8-K - Current report
Nov 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities